Package 0069-1308-10

Brand: retacrit

Generic: epoetin alfa-epbx
NDC Package

Package Facts

Identity

Package NDC 0069-1308-10
Digits Only 0069130810
Product NDC 0069-1308
Product ID 0069-1308_a2e74269-0093-454f-963e-35c7c2f4f1ba
Description

10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1308-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1308-01)

Marketing

Marketing Status
Marketed Since 2018-06-18
Brand retacrit
Generic epoetin alfa-epbx
Sample Package No

Linked Drug Pages (1)

RETACRIT ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "a2e74269-0093-454f-963e-35c7c2f4f1ba", "openfda": {"unii": ["64FS3BFH5W"], "rxcui": ["2047591", "2047596", "2047600", "2047602", "2047606", "2047608", "2047612", "2047614", "2047621", "2047623", "2463731", "2463733", "2463735", "2463737"], "spl_set_id": ["3af26b0d-8ad0-44e1-a538-8bdb5ab39374"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (0069-1308-10)  / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1308-01)", "package_ndc": "0069-1308-10", "marketing_start_date": "20180618"}], "brand_name": "RETACRIT", "product_id": "0069-1308_a2e74269-0093-454f-963e-35c7c2f4f1ba", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Erythropoiesis-stimulating Agent [EPC]", "Erythropoietin [CS]", "Increased Erythroid Cell Production [PE]"], "product_ndc": "0069-1308", "generic_name": "epoetin alfa-epbx", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RETACRIT", "active_ingredients": [{"name": "EPOETIN", "strength": "10000 [iU]/mL"}], "application_number": "BLA125545", "marketing_category": "BLA", "marketing_start_date": "20180618", "listing_expiration_date": "20261231"}